Desq Long
Sign in

Company

Tyra Biosciences, Inc.

TYRA · CIK 0001863127

SEC FORM 4
$8,681.68

Tyra Biosciences, Inc. (TYRA)

Acquisition (code A) of 951 shares at $9.129 per share.

Reporting Person Fuhrman Alan · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394731 · filed 2026-09-17 · View filing →

SEC FORM 4
$26,702.32

Tyra Biosciences, Inc. (TYRA)

Acquisition (code A) of 2,925 shares at $9.129 per share.

Reporting Person Rueb Yuliya · Officer Title Vice President, Finance (PAO) · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394734 · filed 2026-09-17 · View filing →

SEC FORM 4
$7,887.46

Tyra Biosciences, Inc. (TYRA)

Acquisition (code A) of 864 shares at $9.129 per share.

Reporting Person Harris Todd · Officer Title President and CEO · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001193125-26-394738 · filed 2026-09-17 · View filing →

SEC FORM 4
$20,000.03

Tyra Biosciences, Inc. (TYRA)

Purchase of 971.8943 shares at $20.5784 per share.

Reporting Person Verjee Rehan · Transaction Code P

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389333 · filed 2026-09-11 · View filing →